T2DM (TYPE 2 DIABETES MELLITUS)
Clinical trials for T2DM (TYPE 2 DIABETES MELLITUS) explained in plain language.
Never miss a new study
Get alerted when new T2DM (TYPE 2 DIABETES MELLITUS) trials appear
Sign up with your email to follow new studies for T2DM (TYPE 2 DIABETES MELLITUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New diabetes pill shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental tablet called ASC30 in 100 adults with type 2 diabetes. The goal is to see if it safely lowers blood sugar and helps with weight over 13 weeks compared to a placebo. Participants must have stable weight and a BMI of 23 or higher.
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can virtual group visits tame diabetes and heart risks?
Disease control OngoingThis study tests whether virtual group visits—where patients meet online for diabetes education, support, and goal setting—can improve blood sugar control in people with type 2 diabetes who also have heart-related conditions. About 720 adults from participating clinics will take …
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New study aims to replace painful liver biopsies with ultrasound and blood tests
Knowledge-focused OngoingThis study follows 163 obese patients undergoing bariatric surgery to see if non-invasive tools like ultrasound and blood markers can accurately diagnose fatty liver disease (MASLD) and predict diabetes remission. Researchers will compare these tests to liver biopsy results befor…
Matched conditions: T2DM (TYPE 2 DIABETES MELLITUS)
Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:57 UTC